Stable overexpression of human metallothionein-IIA in a heart-derived cell line confers oxidative protection

Toxicology Letters

Volumn 188, Issue 1, 2009, Pages 70-76

  Xue, Wanli ^a,b   Liu, Qiuqu ^a,c   Cai, Lu ^a,c   Wang, Zhilun ^b   Feng, Wenke ^a,b  

^a University of Louisville School of Medicine   (United States)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

H9c2; Metallothionein; Oxidative stress; Stable expression

Indexed keywords

BETA ACTIN; CADMIUM; HYDROETHIDINE; HYDROGEN PEROXIDE; METALLOTHIONEIN II; REACTIVE OXYGEN METABOLITE; ZINC SULFATE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL LINE; CELL STRUCTURE; EVALUATION; GENE VECTOR; HEART PROTECTION; HUMAN; HUMAN CELL; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REOXYGENATION; STAINING; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CADMIUM CHLORIDE; CELL HYPOXIA; CELL LINE; CELL PROLIFERATION; CELL SHAPE; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROGEN PEROXIDE; KINETICS; METALLOTHIONEIN; MYOCYTES, CARDIAC; OXIDANTS; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; TRANSFECTION; UP-REGULATION; ZINC SULFATE;

RATTUS;

EID: 67349281898     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.03.007     Document Type: Article

References (44)

1. Abdel-Mageed A.B., Zhao F., Rider B.J., and Agrawal K.C. Erythropoietin-induced metallothionein gene expression: role in proliferation of K562 cells. Exp. Biol. Med. (Maywood.) 228 (2003) 1033-1039
2. Berthiaume J.M., and Wallace K.B. Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol. Toxicol. 23 (2007) 15-25
3. Cai L., Klein J.B., and Kang Y.J. Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage. J. Biol. Chem. 275 (2000) 38957-38960
4. Feng W., Benz F.W., Cai J., Pierce W.M., and Kang Y.J. Metallothionein disulfides are present in metallothionein-overexpressing transgenic mouse heart and increase under conditions of oxidative stress. J. Biol. Chem. 281 (2006) 681-687
5. Feng W., Cai J., Pierce W.M., Franklin R.B., Maret W., Benz F.W., and Kang Y.J. Metallothionein transfers zinc to mitochondrial aconitase through a direct interaction in mouse hearts. Biochem. Biophys. Res. Commun. 332 (2005) 853-858
6. Haase H., and Maret W. A differential assay for the reduced and oxidized states of metallothionein and thionein. Anal. Biochem. 333 (2004) 19-26
7. Hescheler J., Meyer R., Plant S., Krautwurst D., Rosenthal W., and Schultz G. Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ. Res. 69 (1991) 1476-1486
8. Kagi J.H., and Schaffer A. Biochemistry of metallothionein. Biochemistry 27 (1988) 8509-8515
9. Kang Y.J. The antioxidant function of metallothionein in the heart. Proc. Soc. Exp. Biol. Med. 222 (1999) 263-273
10. Kang Y.J. Metallothionein redox cycle and function. Exp. Biol. Med. (Maywood.) 231 (2006) 1459-1467
11. Kang Y.J., Chen Y., Yu A.D., VossMcCowan M., and Epstein P.N. Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J. Clin. Invest. 100 (1997) 1501-1506
12. Kang Y.J., Li G.Q., and Saari J.T. Metallothionein inhibits ischemia-reperfusion injury in mouse heart. Am. J. Physiol. Heart Circ. Physiol. 276 (1999) H993-H997
13. Kang Y.J., Li Y., Sun X., and Sun X. Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transgenic mice. Am. J. Pathol. 163 (2003) 1579-1586
14. Kang Y.J., Zhou Z.X., Wang G.W., Buridi A., and Klein J.B. Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases. J. Biol. Chem. 275 (2000) 13690-13698
15. Kim A.H., Sheline C.T., Tian M., Higashi T., McMahon R.J., Cousins R.J., and Choi D.W. L-type Ca(2+) channel-mediated Zn(2+) toxicity and modulation by ZnT-1 in PC12 cells. Brain Res. 886 (2000) 99-107
16. Li X., Chen H., and Epstein P.N. Metallothionein protects islets from hypoxia and extends islet graft survival by scavenging most kinds of reactive oxygen species. J. Biol. Chem. 279 (2004) 765-771
17. Menard C., Pupier S., Mornet D., Kitzmann M., Nargeot J., and Lory P. Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J. Biol. Chem. 274 (1999) 29063-29070
18. Maret W. The function of zinc metallothionein: a link between cellular zinc and redox state. J. Nutr. 130 (2000) 1455S-1458S
19. Merten K.E., Feng W., Zhang L., Pierce W., Cai J., Klein J.B., and Kang Y.J. Modulation of cytochrome C oxidase-va is possibly involved in metallothionein protection from doxorubicin cardiotoxicity. J. Pharmacol. Exp. Ther. 315 (2005) 1314-1319
20. Merten K.E., Jiang Y., and Kang Y.J. Zinc inhibits doxorubicin-activated calcineurin signal transduction pathway in H9c2 embryonic rat cardiac cells. Exp. Biol. Med. (Maywood.) 232 (2007) 682-689
21. Murakami M., and Hirano T. Intracellular zinc homeostasis and zinc signaling. Cancer Sci. 99 (2008) 1515-1522
22. Murata H., Ihara Y., Nakamura H., Yodoi J., Sumikawa K., and Kondo T. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J. Biol. Chem. 278 (2003) 50226-50233
23. Nakajima K., Suzuki K., Ozaki N., and Kimura M. Detection of metallothionein in brain. In: Riordan J.F., and Vallee B.L. (Eds). Methods in Enzymology, Metallobiochemistry Part B: Metallothionein and Related Molecules (1991), Academic Press, New York 387-395
24. Nakajima K., and Suzuki K. Immunochemical detection of metallothionein in brain. Neurochem. Int. 27 (1995) 73-87
25. Nath R., Kumar D., Li T., and Singal P.K. Metallothioneins, oxidative stress and the cardiovascular system. Toxicology 155 (2000) 17-26
26. Osborne N.N., and Wood J.P. The beta-adrenergic receptor antagonist metipranolol blunts zinc-induced photoreceptor and RPE apoptosis. Invest. Ophthalmol. Vis. Sci. 47 (2006) 3178-3186
27. Palmiter R.D., Findley S.D., Whitmore T.E., and Durnam D.M. MT-III, a brain-specific member of the metallothionein gene family. Proc. Natl. Acad. Sci. U.S.A 89 (1992) 6333-6337
28. Quaife C.J., Findley S.D., Erickson J.C., Froelick G.J., Kelly E.J., Zambrowicz B.P., and Palmiter R.D. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 33 (1994) 7250-7259
29. Ren J., Privratsky J.R., Yang X., Dong F., and Carlson E.C. Metallothionein alleviates glutathione depletion-induced oxidative cardiomyopathy in murine hearts. Crit. Care Med. 36 (2008) 2106-2116
30. Singla D.K., and McDonald D.E. Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H1590-H1595
31. Singla D.K., Singla R.D., and McDonald D.E. Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway. Am. J. Physiol. Heart Circ. Physiol. 295 (2008) H907-H913
32. Sun X., and Kang Y.J. Prior increase in metallothionein levels is required to prevent doxorubicin cardiotoxicity. Exp. Biol. Med. (Maywood.) 227 (2002) 652-657
33. Sun X.H., Zhou Z.X., and Kang Y.J. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart. Cancer Res. 61 (2001) 3382-3387
34. Theocharis S.E., Margeli A.P., and Koutselinis A. Metallothionein: a multifunctional protein from toxicity to cancer. Int. J. Biol. Markers 18 (2003) 162-169
35. Wallace K.B. Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis. Cardiovasc. Toxicol. 7 (2007) 101-107
36. Wang G.W., Zhou Z.X., Klein J.B., and Kang Y.J. Inhibition of hypoxia/reoxygenation-induced apoptosis in metallothionein-overexpressing cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H2292-H2299
37. Wang J., Song Y., Elsherif L., Song Z., Zhou G., Prabhu S.D., Saari J.T., and Cai L. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation 113 (2006) 544-554
38. Yin X.H., Wu H.Y., Chen Y., and Kang Y.J. Induction of antioxidants by Adriamycin in mouse heart. Biochem. Pharmacol. 56 (1998) 87-93
39. 2 in vitro is modulated by metallothionein. Mol. Cell. Biol. 23 (2003) 8471-8485
40. Zheng H., Liu J., Choo K.H., Michalska A.E., and Klaassen C.D. Metallothionein-I and -II knock-out mice are sensitive to cadmium-induced liver mRNA expression of c-jun and p53. Toxicol. Appl. Pharmacol. 136 (1996) 229-235
41. Zheng H., Liu J., Liu Y., and Klaassen C.D. Hepatocytes from metallothionein-I and II knock-out mice are sensitive to cadmium- and tert-butylhydroperoxide-induced cytotoxicity. Toxicol. Lett. 87 (1996) 139-145
42. Zheng S., Carlson E.C., Yang L., Kralik P.M., Huang Y., and Epstein P.N. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy. J. Am. Soc. Nephrol. 19 (2008) 2077-2085
43. Zhou G., Li X., Hein D.W., Xiang X., Marshall J.P., Prabhu S.D., and Cai L. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. J. Am. Coll. Cardiol. 52 (2008) 655-666
44. Zhou Z., Wang L., Song Z., Saari J.T., McClain C.J., and Kang Y.J. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am. J. Pathol. 166 (2005) 1681-1690